Dec 29, 2017 08:05 am UTC| Business
MONTRAL, Dec. 29, 2017 -- Further to its news release dated December 13, 2017, Siyata Mobile Inc. (the "Company" or "Siyata") (TSX-V:SIM) (OTCQX:SYATF) is pleased to announce that it has closed its previously announced...
Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
Dec 29, 2017 08:05 am UTC| Business
VANCOUVER, British Columbia, Dec. 29, 2017 -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy visit of the Fundación de Investigación...
New number of shares and votes in BTS Group AB (publ)
Dec 29, 2017 07:30 am UTC| Business
STOCKHOLM, SWEDEN – During December, the number of shares and votes in BTS Group AB (publ) increased due to the targeted new issue communicated by press release on December 15, 2017. Following the increase, the total...
SGLA Restructuring Initiative to Accelerate Transformation
Dec 29, 2017 07:06 am UTC| Business
HONG KONG, Dec. 29, 2017 -- Sino Green Land Corp (OTCQB:SGLA) (the "Company" or "SGLA"), today announced SGLA will acquire Hong Kong base company name "Go Sliver Toprich International Limited" ("GSTI"). Go Silver...
Ackrell Capital Publishes “2018 Cannabis Investment Report”
Dec 29, 2017 05:00 am UTC| Business
SAN FRANCISCO, Dec. 28, 2017 -- Ackrell Capital today announced the publication of its "2018 Cannabis Investment Report." Ackrell Capital's 180-page report provides in-depth analysis and insight into the current and...
Helius Medical Technologies Announces Closing of Second Tranche of Private Placement
Dec 29, 2017 00:02 am UTC| Business
NEWTOWN, Pa., Dec. 28, 2017 -- Helius Medical Technologies, Inc. (TSX:HSM) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, is pleased to announce the...
Dec 28, 2017 23:30 pm UTC| Business
– Company to announce FDA clearance to initiate two Phase 3 tabelecleucel clinical studies – SOUTH SAN FRANCISCO, Calif., Dec. 28, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell...